These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2206937)

  • 1. Breast cancer staging and the "alert": an educational dilemma.
    Kennedy BJ
    J Cancer Educ; 1990; 5(2):91-7. PubMed ID: 2206937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy with cyclophosphamide methotrexate and 5-fluorouracil (CMF) in stage II breast cancer in Indian patients.
    Shetty PA; Sarda PK; Majumdar AT; Pai VR; Shinde SR; D'Souza LJ; Pinto JM; Jussawalla DJ
    Indian J Cancer; 1985 Sep; 22(3):239-44. PubMed ID: 3843327
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
    Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
    J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent chemotherapy and radiation for breast conservation treatment of early-stage breast cancer.
    Markiewicz DA; Fox KR; Schultz DJ; Harris EE; Haas JA; Glick JH; Solin LJ
    Cancer J Sci Am; 1998; 4(3):185-93. PubMed ID: 9612601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
    Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
    J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The adjuvant chemotherapy of breast cancer].
    Semiglazov VF; Golubeva OM; Bavli IaL; Ivanova OA; Topuzov EE
    Vopr Onkol; 1992; 38(10):1187-94. PubMed ID: 1343144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early experiences of breast-conservation treatment combined with tamoxifen and CAF chemotherapy for breast cancer of stages I and II.
    Ogawa Y; Nishioka A; Inomata T; Hamada N; Terashima M; Yoshida S; Tanaka Y; Ogoshi S; Araki K; Kumon M
    Radiat Med; 1994; 12(1):29-35. PubMed ID: 8016401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality therapy for locally advanced and limited stage IV breast cancer: the impact of effective non-cross-resistance late-consolidation chemotherapy.
    Blumenschein GR; DiStefano A; Caderao J; Fristenberg B; Adams J; Schweichler LH; Drinkard L
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2633-7. PubMed ID: 10068266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.
    Adjuvant Breast Cancer Trials Collaborative Group
    J Natl Cancer Inst; 2007 Apr; 99(7):506-15. PubMed ID: 17405995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies.
    Goldhirsch A; Gelber R
    NCI Monogr; 1986; (1):55-70. PubMed ID: 3774016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study.
    Mansour EG; Gray R; Shatila AH; Osborne CK; Tormey DC; Gilchrist KW; Cooper MR; Falkson G
    N Engl J Med; 1989 Feb; 320(8):485-90. PubMed ID: 2915651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative surgery and irradiation (QUART) in the treatment of 243 stage I-II breast cancer patients.
    Gasparini G; Panizzoni GA; Dal Fior S; Germani B; Dall'Antonia F; Segato G; Meli S; Pozza F
    Anticancer Res; 1991; 11(4):1635-40. PubMed ID: 1746920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative chemotherapy in primarily inoperable cancer of the breast.
    Luboinski G; Nagadowska M; Pienkowski T
    Eur J Surg Oncol; 1991 Dec; 17(6):603-7. PubMed ID: 1743309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of adjuvant chemotherapy for breast cancer in a community practice.
    Rosenberg A; Winer EP; Cadman E
    Conn Med; 1985 May; 49(5):281-5. PubMed ID: 3839177
    [No Abstract]   [Full Text] [Related]  

  • 18. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
    Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N
    J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant systemic therapy for breast cancer. Issues for primary care physicians.
    Berkowitz LD; Love N
    Postgrad Med; 1995 Oct; 98(4):85-8, 91, 94. PubMed ID: 7567725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tamoxifen after chemotherapy in hormone receptor-positive, node-negative breast cancer.
    Panasci LC
    J Clin Oncol; 2006 May; 24(15):2392; author reply 2392. PubMed ID: 16710042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.